<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Simplify.drugs on Medium]]></title>
        <description><![CDATA[Stories by Simplify.drugs on Medium]]></description>
        <link>https://medium.com/@scoopmed?source=rss-2bd4b1e653e9------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*Tll4JYfsLbpPjuQxCkJtfw@2x.jpeg</url>
            <title>Stories by Simplify.drugs on Medium</title>
            <link>https://medium.com/@scoopmed?source=rss-2bd4b1e653e9------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sat, 14 Nov 2026 09:08:15 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@scoopmed/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Vonoprazan: The stronger PPI ?]]></title>
            <link>https://medium.com/@scoopmed/vonoprazan-the-stronger-ppi-7793f515f95b?source=rss-2bd4b1e653e9------2</link>
            <guid isPermaLink="false">https://medium.com/p/7793f515f95b</guid>
            <category><![CDATA[pharmacology]]></category>
            <category><![CDATA[pharmaceutical]]></category>
            <category><![CDATA[medicine]]></category>
            <dc:creator><![CDATA[Simplify.drugs]]></dc:creator>
            <pubDate>Thu, 17 Nov 2022 08:45:01 GMT</pubDate>
            <atom:updated>2022-11-17T08:45:01.347Z</atom:updated>
            <content:encoded><![CDATA[<h3>Vonoprazan: The stronger PPI ?</h3><p>Vonoprazan belongs to a new class of drugs called potassium-competitive acid blockers</p><blockquote>Inhibits H+K+-ATPase by competitively blocking the potassium-binding site</blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*zqUoPn1Po-ByXIjLLj7wOA.jpeg" /></figure><p><strong>Compared to PPI:</strong></p><p>More suppression of gastric acid secretion</p><p>Acid-catalysed activation is not necessary for the action</p><p>More rapid onset of action (day 1)</p><p>Bioavailability is not affected by food</p><p>Primarily metabolised by CYP3A4</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=7793f515f95b" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Red man syndrome]]></title>
            <link>https://medium.com/@scoopmed/red-man-syndrome-cb86a465ac7a?source=rss-2bd4b1e653e9------2</link>
            <guid isPermaLink="false">https://medium.com/p/cb86a465ac7a</guid>
            <category><![CDATA[pharmacology]]></category>
            <dc:creator><![CDATA[Simplify.drugs]]></dc:creator>
            <pubDate>Tue, 31 Mar 2020 11:40:23 GMT</pubDate>
            <atom:updated>2020-03-31T11:40:23.140Z</atom:updated>
            <content:encoded><![CDATA[<p>Most commonly caused by vancomycin.</p><p>Other drugs implicated</p><p>CART:</p><p>C: Cefepime, ciprofloxacin, cremophor (excipient in paclitaxel)</p><p>A: Amphotericin B</p><p>R: Rifampin</p><p>T: Teicoplanin, telavancin</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=cb86a465ac7a" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Digoxin and Eubacterium lentum]]></title>
            <link>https://medium.com/@scoopmed/digoxin-and-eubacterium-lentum-f6d5695a7962?source=rss-2bd4b1e653e9------2</link>
            <guid isPermaLink="false">https://medium.com/p/f6d5695a7962</guid>
            <category><![CDATA[pharmacology]]></category>
            <dc:creator><![CDATA[Simplify.drugs]]></dc:creator>
            <pubDate>Wed, 26 Feb 2020 07:28:08 GMT</pubDate>
            <atom:updated>2020-02-26T07:28:08.335Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*hMUJGISLJVJgrXbSvWXRfw.png" /></figure><p>· Digoxin is metabolized to inactive metabolites, called digoxin reduction products by a bacterium called <em>Eubacterium lentum.</em></p><p>· <em>Eubacterium lentum</em> is present as normal flora in approximately 10 percent of patients.</p><p>· Broad spectrum antibiotics like erythromycin/ tetracycline can alter the flora and increase digoxin levels.</p><p>Source: <a href="https://www.aafp.org/afp/1998/0315/p1239.html">https://www.aafp.org/afp/1998/0315/p1239.html</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f6d5695a7962" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Methyldopa and positive Coombs test]]></title>
            <link>https://medium.com/@scoopmed/methyldopa-and-positive-coombs-test-6b88480c9925?source=rss-2bd4b1e653e9------2</link>
            <guid isPermaLink="false">https://medium.com/p/6b88480c9925</guid>
            <category><![CDATA[pharmacology]]></category>
            <dc:creator><![CDATA[Simplify.drugs]]></dc:creator>
            <pubDate>Thu, 20 Feb 2020 05:18:25 GMT</pubDate>
            <atom:updated>2020-02-20T05:18:25.571Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*9gocyhw5fLuGHaHvbW_pog.png" /></figure><p>▪️Around 20% of patients will have positive Coombs test.</p><p>▪️Positive coombs test is not an indication to stop treatment.</p><p>▪️Only around 1–5% of patients with positive Coombs test may develop hemolytic anemia: discontinuation is required; hemolytic anemia resolves within weeks after discontinuation whereas Coombs test remains positive for about a year.</p><p>▪️Glucocorticoids are required for severe cases.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6b88480c9925" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Thiazides and chronic hypertension]]></title>
            <link>https://medium.com/@scoopmed/thiazides-and-chronic-hypertension-94038a5c2bfb?source=rss-2bd4b1e653e9------2</link>
            <guid isPermaLink="false">https://medium.com/p/94038a5c2bfb</guid>
            <category><![CDATA[pharmacy]]></category>
            <dc:creator><![CDATA[Simplify.drugs]]></dc:creator>
            <pubDate>Wed, 12 Feb 2020 11:27:00 GMT</pubDate>
            <atom:updated>2020-02-12T11:27:00.139Z</atom:updated>
            <content:encoded><![CDATA[<p>On long term treatment with thiazides, cardiac output returns to pretreatment values, and extracellular volume returns to almost normal due to compensatory responses like activation of the RAS.</p><p>The hypotensive effect during long-term therapy is therefore primarily attributed to decreased vascular resistance. The negative Na+ balance has an indirect effect of decreasing peripheral vascular resistance.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=94038a5c2bfb" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Desmopressin action on V2 receptors]]></title>
            <link>https://medium.com/@scoopmed/desmopressin-action-on-v2-receptors-12d982a13dbf?source=rss-2bd4b1e653e9------2</link>
            <guid isPermaLink="false">https://medium.com/p/12d982a13dbf</guid>
            <category><![CDATA[pharmacology]]></category>
            <dc:creator><![CDATA[Simplify.drugs]]></dc:creator>
            <pubDate>Mon, 10 Feb 2020 09:30:54 GMT</pubDate>
            <atom:updated>2020-02-10T09:30:54.436Z</atom:updated>
            <content:encoded><![CDATA[<p>Remember the distribution of V2 receptors in renal cells.</p><ul><li>Principal cells of the renal collecting duct system</li><li>Epithelial cells in TAL</li></ul><p>Apart from the principal cells, they are present in thick ascending limb also. So, there should be some additional mechanism of action.</p><p>Major action:</p><p>Rapid insertion of preformed aquaporin-2 into apical membrane of principal cells in collecting duct and increasing water permeability</p><p>Minor actions:</p><ul><li>Long term increase in expression of aquaporin-2</li><li>Rapid activation and translocation of Na+/K+/2Cl- symporter in TAL</li><li>Long term increase in expression of Na+/K+/2Cl- symporter</li><li>Rapid activation of VRUT in IMCD</li></ul><p>Minor actions result in increase in medullary osmolality and further adds to the water conservation.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=12d982a13dbf" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Thiazide diuretics and their paradoxical use in nephrogenic diabetes insipidus]]></title>
            <link>https://medium.com/@scoopmed/thiazide-diuretics-and-their-paradoxical-use-in-nephrogenic-diabetes-insipidus-8c8b6ad190b7?source=rss-2bd4b1e653e9------2</link>
            <guid isPermaLink="false">https://medium.com/p/8c8b6ad190b7</guid>
            <category><![CDATA[pharma]]></category>
            <dc:creator><![CDATA[Simplify.drugs]]></dc:creator>
            <pubDate>Thu, 06 Feb 2020 12:34:12 GMT</pubDate>
            <atom:updated>2022-11-16T15:08:06.313Z</atom:updated>
            <content:encoded><![CDATA[<p>Thiazides are the mainstay in treatment of nephrogenic diabetes insipidus.</p><p>Thiazides reduce the kidney’s ability to excrete free water: They increase proximal tubular water reabsorption secondary to volume contraction and block the ability of the DCT to form dilute urine. This effect results in an increase in urine osmolality.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*KJCjql2mZppOOqKeSS6NUg.jpeg" /></figure><p>Note: Thiazides are also effective in central diabetes insipidus and is being investigated extensively in this condition.</p><p>Source: <a href="https://www.ncbi.nlm.nih.gov/pubmed/26130110">Thiazide Diuretics in the Management of Young Children with Central Diabetes Insipidus.</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8c8b6ad190b7" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Penicillin G: Conditions where it is considered as first line/ drug of choice]]></title>
            <link>https://medium.com/@scoopmed/penicillin-g-conditions-where-it-is-considered-as-first-line-drug-of-choice-7ba5704090ea?source=rss-2bd4b1e653e9------2</link>
            <guid isPermaLink="false">https://medium.com/p/7ba5704090ea</guid>
            <category><![CDATA[pharmacology]]></category>
            <dc:creator><![CDATA[Simplify.drugs]]></dc:creator>
            <pubDate>Tue, 04 Feb 2020 04:21:34 GMT</pubDate>
            <atom:updated>2020-02-04T04:21:34.250Z</atom:updated>
            <content:encoded><![CDATA[<ul><li>Syphilis: highly effective and only proven treatment in pregnant women</li><li>Actinomycosis</li><li>Rat bite fever</li><li>Listeria monocytogenes infections</li><li>Pasteurella multicida infections</li></ul><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=7ba5704090ea" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Acetazolamide in acute mountain sickness]]></title>
            <link>https://medium.com/@scoopmed/acetazolamide-in-acute-mountain-sickness-87766eca82b6?source=rss-2bd4b1e653e9------2</link>
            <guid isPermaLink="false">https://medium.com/p/87766eca82b6</guid>
            <category><![CDATA[pharma]]></category>
            <dc:creator><![CDATA[Simplify.drugs]]></dc:creator>
            <pubDate>Mon, 03 Feb 2020 12:27:01 GMT</pubDate>
            <atom:updated>2020-02-03T12:27:01.664Z</atom:updated>
            <content:encoded><![CDATA[<p>Acetazolamide, a carbonic hydrase inhibitor is indicated in prophylaxis of acute mountain sickness.</p><p>Rationale:</p><blockquote>Exact mechanism is unknown.</blockquote><p>CA inhibitors action on renal tubules results in bicarbonaturia and metabolic acidosis.</p><p>The above action results in offsetting hyperventilation-induced respiratory alkalosis and allowance of chemoreceptors to respond more fully to hypoxic stimuli at altitude.</p><p>Other factors that can also contribute to its efficacy:</p><p>Improvements in ventilation from tissue respiratory acidosis</p><p>Improvements in sleep quality from carotid body CA inhibition</p><p>Effects of diuresis</p><p>Sources:</p><p><a href="https://www.ncbi.nlm.nih.gov/pubmed/17023566">https://www.ncbi.nlm.nih.gov/pubmed/17023566</a> <a href="https://wwwnc.cdc.gov/travel/yellowbook/2020/noninfectious-health-risks/high-altitude-travel-and-altitude-illness">https://wwwnc.cdc.gov/travel/yellowbook/2020/noninfectious-health-risks/high-altitude-travel-and-altitude-illness</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=87766eca82b6" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Why levodopa is not used in drug induced psychosis(DIP)?]]></title>
            <link>https://medium.com/@scoopmed/why-levodopa-is-not-used-in-drug-induced-psychosis-dip-b762186741f3?source=rss-2bd4b1e653e9------2</link>
            <guid isPermaLink="false">https://medium.com/p/b762186741f3</guid>
            <category><![CDATA[pharmacology]]></category>
            <category><![CDATA[medicine]]></category>
            <category><![CDATA[drugs]]></category>
            <dc:creator><![CDATA[Simplify.drugs]]></dc:creator>
            <pubDate>Mon, 20 Jan 2020 14:49:14 GMT</pubDate>
            <atom:updated>2020-01-20T14:54:40.175Z</atom:updated>
            <content:encoded><![CDATA[<p><strong>Why levodopa is not used in drug induced psychosis(DIP)?</strong></p><p>Atypical antipsychotics are usually implicated in DIP.</p><p>The mechanism of antipsychotic efficacy is attributed to its D2 antagonism.</p><p>Use of levodopa in such patients:</p><ul><li>Risk of antagonising the antipsychotic effect by competitive antagonism</li><li>Risk of psychosis caused by levodopa itself</li></ul><p>Despite the above theoretical limitations, there are limited number of trials done to look into the efficacy and safety.</p><p><strong>What do these trials say ?</strong></p><p>Do not report any significant increase in psychosis</p><p>Also benefits obtained by levodopa treatment are disappointing and non-significant</p><p><strong>Note</strong>: the above conclusions are for neuroleptic induced Parkinsonism</p><p>For other drug induced Parkinsonism like valproate, levodopa treatment has been found to be beneficial.</p><p><strong>Source:</strong></p><p><a href="https://jnnp.bmj.com/content/jnnp/51/6/850.full.pdf">https://jnnp.bmj.com/content/jnnp/51/6/850.full.pdf</a></p><p><a href="https://www.dovepress.com/drug-induced-parkinsonism-diagnosis-and-management-peer-reviewed-fulltext-article-JPRLS">https://www.dovepress.com/drug-induced-parkinsonism-diagnosis-and-management-peer-reviewed-fulltext-article-JPRLS</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b762186741f3" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>